Michael Schweizer, MD

/content/dam/www/provider-photos/s/michael-schweizer/provider-michael-schweizer-directory-1x.jpg
/content/dam/www/provider-photos/s/michael-schweizer/provider-michael-schweizer-directory-2x.jpg
Schweizer
Michael Schweizer, MD

Michael Schweizer, MD

  • Interim Director, Phase 1 Clinical Trials Program, Fred Hutch
  • Associate Professor, Clinical Research Division, Fred Hutch
  • Associate Professor, Division of Hematology and Oncology, University of Washington School of Medicine

Medical Oncology

“My goal is to provide patient care that is driven by science combined with compassion and empathy.”

— Dr. Schweizer


Why do you practice oncology?

Michael Schweizer, MD, decided to work in health care because he wanted to feel intellectually challenged in his career and, more importantly, he wanted to do something that would allow him to help people. Medicine was the perfect fit. “Early on in my training, I realized that you often see the best in people when they are faced with a cancer diagnosis,” Dr. Schweizer said. “The hope that my patients have in spite of being diagnosed with such serious illnesses is inspiring. It’s my patients’ hope that motivates me and makes me want to be a part of working toward cures.”

Dr. Schweizer’s research involves translational genitourinary cancer. “My goal is to help reduce the morbidity and mortality associated with diseases like prostate cancer through developing novel drug therapies. Cancer is a formidable foe, but one that I believe we can vanquish. I hope to be a part of bringing the dream of a world without cancer into reality. I hope to see cancer cured in my lifetime.” 

Provider Background

Area of Clinical Practice
Genitourinary cancers

Diseases Treated

Penile Cancer

Testicular Cancer

Languages

English

Education, Experience and Certifications

Medical Degree
Temple University School of Medicine

Residency
University of Chicago

Fellowship
Johns Hopkins University

Board Certification
Internal Medicine, 2011, Medical Oncology, 2013, American Board of Internal Medicine

Stories

All news
‘Good cancer’? Views vary on a sunny phrase Many patients and doctors refuse to apply the ‘g’ word to highly curable cancers, but some survivors draw hope from the ‘good’ November 10, 2016
'Bipolar' therapy: Treating advanced prostate cancer with high-dose testosterone Men with a certain type of aggressive prostate cancer may benefit from therapy that cycles hormones through high peaks and low valleys, small study finds January 7, 2015

Clinical Trials

We make promising new treatments available to you through studies called clinical trials led by Fred Hutch physicians. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your physician can decide if a study is right for you. 

Find a Clinical Trial Led by Dr. Schweizer

Publications

Many of our Fred Hutch physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch physician has written. 

View Publications by Dr. Schweizer

Your Care Team

At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes physicians, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like registered dietitians, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders. 

Insurance

Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.